Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction
Related Experiment Video
Updated: Oct 12, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
Francesca Chiara Pignalosa1,2, Antonella Desiderio1,2, Paola Mirra1,2
1Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Abstract:
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia, responsible for the onset of several long-term complications. Recent evidence suggests that cognitive dysfunction represents an emerging complication of DM, but the underlying molecular mechanisms are still obscure. Dopamine (DA), a neurotransmitter essentially known for its relevance in the regulation of behavior and movement, modulates cognitive function, too. Interestingly, alterations of the dopaminergic system have been observed in DM. This review aims to offer a comprehensive overview of the most relevant experimental results assessing DA's role in cognitive function, highlighting the presence of dopaminergic dysfunction in DM and supporting a role for glucotoxicity in DM-associated dopaminergic dysfunction and cognitive impairment. Several studies confirm a role for DA in cognition both in animal models and in humans. Similarly, significant alterations of the dopaminergic system have been observed in animal models of experimental diabetes and in diabetic patients, too. Evidence is accumulating that advanced glycation end products (AGEs) and their precursor methylglyoxal (MGO) are associated with cognitive impairment and alterations of the dopaminergic system. Further research is needed to clarify the molecular mechanisms linking DM-associated dopaminergic dysfunction and cognitive impairment and to assess the deleterious impact of glucotoxicity.
Insights
Diabetes mellitus (DM) can impair cognitive function by affecting dopamine (DA), a neurotransmitter crucial for cognition. Glucotoxicity, driven by high blood sugar, appears to underlie this DM-associated dopaminergic dysfunction and cognitive decline.
Area of Science:
- Neuroscience
- Endocrinology
- Metabolic Disorders
Background:
- Diabetes mellitus (DM) is a chronic metabolic disorder with hyperglycemia, leading to long-term complications.
- Cognitive dysfunction is an emerging complication of DM, with unclear molecular mechanisms.
- Dopamine (DA), a neurotransmitter, significantly influences cognitive functions.
Purpose of the Study:
- To review experimental evidence on the role of dopamine (DA) in cognitive function.
- To highlight dopaminergic system alterations in DM.
- To explore the link between glucotoxicity, dopaminergic dysfunction, and cognitive impairment in DM.
Main Methods:
- Comprehensive literature review of experimental studies.
- Analysis of findings from animal models and human studies.
- Examination of evidence linking advanced glycation end products (AGEs) and methylglyoxal (MGO) to DM complications.
Main Results:
- Dopamine (DA) plays a confirmed role in cognitive function across species.
- Alterations in the dopaminergic system are evident in experimental diabetes models and human patients.
- Advanced glycation end products (AGEs) and methylglyoxal (MGO) are implicated in cognitive impairment and dopaminergic dysfunction in DM.
Conclusions:
- Glucotoxicity is a likely contributor to dopaminergic dysfunction and cognitive impairment in DM.
- Further research is required to elucidate the precise molecular mechanisms.
- Understanding these mechanisms is crucial for assessing the impact of glucotoxicity on cognitive health in diabetes.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Parkinson's Disease: Overview
Diabetes: Symptoms, Diagnosis, and Complications
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

